Laboratory Services for Public Health Division

The solicitation number 40-66500-24-77763 issued by the New Mexico Department of Health (NMDOH) Public Health Division seeks to procure comprehensive clinical laboratory testing services. The contract focuses on delivering a wide range of diagnostic laboratory services including infectious disease screening for conditions such as HIV, Hepatitis C, sexually transmitted infections (STIs) like Chlamydia and Gonorrhea, as well as other relevant public health testing such as drug screening and diagnostic panels. These services are specified by CPT codes with associated unit prices and quantities, covering tests like NAAT assays, viral load quantifications, serologies, and reflex confirmatory testing protocols that ensure accurate diagnostic outcomes in support of public health monitoring and intervention efforts within the State of New Mexico. The place of performance is New Mexico, with FOB destination terms indicating delivery of services results directly to the NMDOH facilities. The estimated contract value ranges from approximately $1.29 million to $1.56 million, depending on the inclusion of reflex testing charges for confirmatory and follow-up tests triggered under defined clinical conditions. Payment terms are net 30, with vendor invoices expected to be submitted accordingly though specific invoicing systems were not detailed. While there is no formal set-aside or socioeconomic classification included, the tabulations identify the Center for Disease Detection as a participating bidder. The contract documentation does not contain standard FAR or DFARS clauses, explicit special contract requirements, or formal evaluation factors and award criteria; it primarily includes technical descriptions of laboratory testing services and pricing. Contract administration information is limited, with a single buyer contact named but no contracting officer or COR identified. Overall, this procurement facilitates critical laboratory screening services to support public health initiatives in New Mexico without extensive regulatory clause overlay, emphasizing clinical service delivery and test accuracy per established CPT coding protocols.